The UAE is one of the countries that have the highest prevalence of diabetes. The number of diabetic cases has been continuously increasing for last few years on account of rising number of elder people, lifestyle change and unhealthy diet. According to our new research report "Diabetes Market in UAE", the diabetes care market in the UAE is projected to grow at a CAGR of nearly 8.5% during 2010-2012.
The new report includes an extensive study of the diabetes care market in the UAE, with focus on present and future trends to enable clients understand the market dynamic. The increasing prevalence of diabetes has become a serious concern for the government as it is putting an extra burden on the country's healthcare spending.
Our research has found that the prevalence of diabetes has reached an alarming level and one out of every five persons in the country is suffering from the disease. With the increasing prevalence of diabetes, several other associated chronic diseases like CVD have become more common among people and putting more financial burden on the government. To counter this problem, there is an urgent need to promote diabetes care programs which include both preventive and conclusive efforts.
The report has studied the diabetes care market by breaking it into two segments - diabetic I and II. The diabetic I condition is associated with the less production of insulin in the body and thus there is a huge demand for insulin in the country. The diabetic II condition is associated with non-insulin treatment part. In this context, our report contains detailed information about the market of both insulin and non-insulin segments along with their future prospects.
"Diabetes Market in UAE" provides a complete overview of the UAE diabetes care market. It also helps clients with critical details about the future prospects of the UAE diabetes care market, supplemented with quantitative data and rational analysis of potential demand areas. The research study also throws light on driving factors that have contributed to the upsurge of diabetic market together with challenges. It also contains critical information about key players along with their business strategies and area of expertise. This will provide clients an additional edge over their competitors while devising business plans.
For more information visit: http://www.rncos.com/Report/IM247.htm |
